Common Equity: The sum of all common equity items.
Zhengye Biotechnology Holding Limited (ZYBT) had Common Equity of $48.30M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$24.33M |
|
$50.24M |
|
$58.53M |
|
$67.58M |
|
$18.62M |
|
$0.66M |
|
$0.66M |
|
$19.28M |
|
|
Common Equity |
$48.30M |
$45.18M |
|
$48.30M |
|
-- |
|
| Cash Flow Statement Financials | |
$5.62M |
|
$-3.79M |
|
$-3.03M |
|
$3.72M |
|
$2.55M |
|
$-1.18M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|